## Sharda Cropchem Ltd: Comprehensive Financial Analysis

This analysis utilizes the provided JSON data to evaluate Sharda Cropchem Ltd.  However, due to the absence of complete quarterly and annual financial data within the JSON, certain aspects of the analysis will be limited.  The analysis will focus on the available data and highlight areas where more information is needed for a complete assessment.

**1. Company Overview:**

Sharda Cropchem Ltd. operates in the Agro Chemicals sector, specifically within the Pesticides/Agrochemicals industry in India.  Its primary business is the export of agrochemicals (both technical grade and formulations) and other non-agro products.  The company's market position is described as part of BSE SmallCap, BSE Allcap, and BSE Commodities indices.  No specific market share or notable achievements are detailed in the provided data.

**2. Key Financial Metrics:**

* **Market Cap:** ₹ 7,143 Cr.
* **Current Price:** ₹ 792
* **High/Low (52-week):** ₹ 887 / ₹ 318
* **P/E Ratio:** 32.8
* **Book Value:** ₹ 254
* **Dividend Yield:** 0.38%
* **ROCE:** 4.27%
* **ROE:** 1.42%
* **Face Value:** ₹ 10.0

**3. Strengths and Weaknesses:**

**Strengths:**

* **Almost Debt-Free:** The provided "Other Insights" section mentions the company is almost debt-free, which is a significant financial strength.
* **Healthy Dividend Payout:**  A 38.7% dividend payout (if accurate) indicates a commitment to returning value to shareholders.

**Weaknesses:**

* **Low ROCE and ROE:**  The ROCE (4.27%) and ROE (1.42%) are significantly low, suggesting suboptimal capital efficiency and profitability.
* **Poor Sales Growth:**  The "Other Insights" section highlights poor sales growth (9.63% over five years), indicating challenges in revenue generation.
* **High Debtor Days:**  High debtor days (173 days, as mentioned in "Other Insights") suggest potential issues with receivables management and cash flow.
* **Inconsistent Profitability:**  The provided CAGR for profit shows significant inconsistency and negative growth over several periods.  The TTM growth of 14% is positive, but needs further investigation to determine sustainability.


**4. Performance Trends:**

This section cannot be fully analyzed due to the missing quarterly and annual financial data in the JSON.  The available data points to inconsistent profitability and sales growth.  A complete analysis requires the missing data to assess trends in sales, expenses, operating profit margins, balance sheet health, and cash flow.

**5. Growth Metrics:**

* **Sales CAGR:** 10-year (15%), 5-year (10%), 3-year (10%), TTM (-6%) – Shows slowing growth, with negative growth in the most recent period.
* **Profit CAGR:** 10-year (-11%), 5-year (-31%), 3-year (-48%), TTM (14%) –  Highly volatile and largely negative profit growth.
* **Stock Price CAGR:** 10-year (12%), 5-year (30%), 3-year (36%), 1-year (84%) –  Significant stock price appreciation, especially recently, which may not be fully justified by underlying fundamentals.
* **ROE:** 10-year (15%), 5-year (13%), 3-year (12%), Last Year (1%) –  Significant decline in ROE, indicating deteriorating profitability.

**6. Comparison to Benchmarks:**

Sharda Cropchem's P/E ratio (32.8) is comparable to some peers (e.g., P I Industries), but its ROCE (4.27%) is significantly lower than most peers.  Its market capitalization is also considerably smaller.  The quarterly sales and profit figures show that Sharda Cropchem has a much smaller scale of operations compared to its peers.  Further analysis is needed to determine if the company is appropriately valued relative to its peers considering its lower profitability and smaller scale.

**7. Stock Valuation:**

Based on the limited data, Sharda Cropchem appears to be potentially overvalued.  The high P/E ratio (32.8) relative to its low ROCE and ROE suggests the market may be pricing in future growth that is not yet reflected in the company's current financial performance.  The Price-to-Book ratio (792/254 ≈ 3.1) is also relatively high.  The significant recent stock price appreciation (84% in one year) further raises concerns about potential overvaluation.  A more detailed analysis, including discounted cash flow (DCF) modeling, would be necessary to confirm this assessment.

**8. Recommendations and Confidence Levels:**

The lack of complete financial data significantly limits the confidence level of any recommendation.  However, based on the available information:

* **Short-term (3-6 months):** Hold or cautiously sell.  The recent stock price surge may be unsustainable given the weak fundamentals.  **Confidence Level: Low**
* **Medium-term (6-12 months):** Hold with caution.  Monitor financial performance closely.  If the company demonstrates significant improvement in profitability and sales growth, the outlook could improve.  **Confidence Level: Low**
* **Long-term (1+ years):**  Further investigation is needed.  The company's long-term prospects depend heavily on its ability to improve operational efficiency, increase profitability, and demonstrate sustainable growth.  **Confidence Level: Low**

**9. Final Verdict:**

Sharda Cropchem Ltd. presents a mixed picture.  While the company benefits from being almost debt-free and maintains a dividend payout, its low profitability, inconsistent growth, and high debtor days raise significant concerns.  The recent stock price appreciation appears to be out of sync with the underlying financial performance.  The analysis suggests potential overvaluation.  However, the lack of complete financial data prevents a definitive conclusion.  Further investigation, including a thorough review of quarterly and annual reports, is crucial before making any investment decisions.  The confidence level in any recommendation is currently low due to the data limitations.  A more comprehensive dataset is required to improve the accuracy and confidence of this analysis.
